Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
2 studies found for:    20471193 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Pharmacogenetic Approach to Anti-platelet Therapy for the Treatment of ST-segment Elevation Myocardial Infarction (STEMI)
Condition: STEMI
Interventions: Genetic: Point-of-Care Genetic Testing;   Drug: Prasugrel
2 Completed ReAssessment of Anti-Platelet Therapy Using an InDividualized Strategy Based on GENetic Evaluation
Conditions: Stable Coronary Artery Disease;   Acute Coronary Syndrome;   Percutaneous Coronary Intervention
Intervention: Genetic: Point-of-care genetic screening with subsequent prasugrel administration to CYP2C19*2 carriers

Indicates status has not been verified in more than two years